Inactive Instrument

Highlights GW Pharmaceuticals plc Other OTC

Equities

GWPRF

GB0030544687

Highlights

Unlock all the news: Be the first to know and act before the market!

Jazz Pharmaceuticals : U.S. FDA approves expanded use of Jazz Pharma's sleep disorder drug Xywav	21-08-12	RE
Jazz Pharmaceuticals' : Subsidiary Gets UK Approval for Epidyolex in Patients With Tuberous Sclerosis Complex-Related Seizures	21-08-10	MT
Gw Pharmaceuticals Receives Approval for Epidyolex (Cannabidiol) from the MHRA for the Treatment of Seizures Associated with Tuberous Sclerosis Complex	21-08-10	CI
Jazz Pharmaceuticals : Updates 2021 Full-Year Guidance Following GW Pharmaceuticals Buy	21-06-17	MT
Jazz Pharmaceuticals : Updates FY2021 Outlook to Reflect GW Pharmaceuticals Purchase	21-06-17	MT
Palla Pharma : Names New CEO; Shares Soar 18%	21-05-26	MT
Jazz Pharmaceuticals : Completes Purchase of GW Pharmaceuticals	21-05-05	MT
Jazz Pharmaceuticals plc completed the acquisition of GW Pharmaceuticals plc.	21-05-04	CI
Gw Pharmaceuticals plc Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-03	CI
GW Pharmaceuticals : Shareholders' Green-light $7.2 Billion Sale To Jazz Pharmaceuticals	21-04-26	MT
GW Pharmaceuticals : Shareholders OK Takeover by Jazz Pharmaceuticals	21-04-23	MT
GW Pharmaceuticals plc Receives European Commission Approval for EPIDYOLEX® (Cannabidiol) for the Treatment of Seizures Associated with Tuberous Sclerosis Complex	21-04-20	CI
Takeda Pharmaceutical : buys epilepsy treatment rights from Ovid for up to $856 million	21-03-03	RE
GW Pharmaceuticals : Receives Positive Opinion for Epidyolex Application in EU	21-02-26	MT
GW Pharmaceuticals plc Receives Positive CHMP Opinion for Epidyolex (Cannabidiol) for Use as Treatment of Seizures Associated with Tuberous Sclerosis Complex	21-02-26	CI
GW Pharmaceuticals : Reports Wider Q4 Losses, Higher Revenue	21-02-16	MT
GW Pharmaceuticals : Earnings Flash (GWPH) GW PHARMACEUTICALS Reports Q4 Revenue $148.2M	21-02-16	MT
GW Pharmaceuticals : Earnings Flash (GWPH) GW PHARMACEUTICALS Posts Q4 EPS $-0.08	21-02-16	MT
Gw Pharmaceuticals plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2020	21-02-16	CI
GW Pharmaceuticals : Medical cannabis company Northern Leaf eyes London listing later this year	21-02-12	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights GW Pharmaceuticals plc Other OTC

Equities

GWPRF

GB0030544687

Highlights

Filters